OrbiMed’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2013
Q4
Sell
-31,500
Closed -$863K 128
2013
Q3
$863K Buy
+31,500
New +$863K 0.02% 107